Layla review

Layla sells compounded semaglutide and tirzepatide as injections or oral drops on monthly and quarterly plans, each opening with a discounted first month before stepping up to $297 and $399, or $199 and $299 on the quarterly terms.

By Grant Ashford, Founder & Pricing EditorAugust 2026

Est. first month

From $297/mo

Save ~78% vs brand-name

$297/mo month-to-month ($199/mo on a quarterly plan; $197 first month)

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.

Pricing to watch. Layla runs four plans and every one of them steps up after month one: semaglutide is $197 then $297 monthly, or $99 then $199 quarterly; tirzepatide is $199 then $399 monthly, or $99 then $299 quarterly. Its FAQ separately says GLP-1 medication "starts at $1299", which is the brand-inclusive program and not any of the four. Three different price stories on one site.

How much does Layla cost?

The price Layla publishes is $297/mo month-to-month ($199/mo on a quarterly plan; $197 first month). Tirzepatide is listed at $399/mo month-to-month ($299/mo on a quarterly plan; $199 first month). We flag this one to watch: confirm the ongoing rate with Layla before you count on it, because a low first month can step up afterward. That works out about 78% under our ~$1,349/mo brand-name cash reference.

Semaglutide: $297/mo month-to-month ($199/mo on a quarterly plan; $197 first month)
Tirzepatide: $399/mo month-to-month ($299/mo on a quarterly plan; $199 first month)
Coverage: Coverage not published
Brand-name: Yes

The Value Score card

Layla scored on our six published factors. See the methodology.

Lowest Real Price72/100

No Teaser-Rate Bait90/100

Nationwide Availability45/100

Both Molecules98/100

Easy Cancellation58/100

Reputation65/100

Why it's a deal

All four plans show the first-month price and the ongoing price side by side, so the step-up is visible before purchase rather than after
Both molecules are offered as injections and as oral drops, and a brand-inclusive route exists for anyone who wants it
Cancel any time is stated on every plan card
Prescription, medication and shipping are described as included in each plan price

Read the fine print

Every plan is a teaser: the first month is $99 to $199 and the ongoing rate is $199 to $399 depending which of the four you pick
Layla's FAQ says GLP-1 medication "starts at $1299" while its plan cards start at $99, and nothing on the page reconciles the two
The homepage was running a "Cyber Week is here" banner in late August, so its promotional messaging is not maintained
The states Layla serves are not published, and its support line uses a UK number format

The bottom line

Best for: Someone who will read which of Layla's four plans they are on before the second charge lands. Layla sells compounded semaglutide and tirzepatide as injections or oral drops on monthly and quarterly plans, each opening with a discounted first month before stepping up to $297 and $399, or $199 and $299 on the quarterly terms.

Ranked #157 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Get this deal

Compare with other deals

The programs scoring closest to Layla, out of 426 others we track.

Shopping Layla against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Layla, and every program that undercuts or outscores it — starting with GoodRx, the closest match on score — is ranked on the Layla alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Layla's own website on August 27, 2026; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Layla's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals